Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition
Clinical trial NCT02534038 · TERMINATED
Trial details
- NCT number
- NCT02534038
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2017-10-03
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.